AVP and metabolic dysfunction-associated steatotic liver disease: A striking observation is that participants with metabolic syndrome, and/or related conditions, such as nonalcoholic fatty liver disease (NAFLD), often have elevated concentrations of vasopressin, as determined by measuring its stable analog copeptin (16–19), a stable peptide derived from the precursor of vasopressin (20).